Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05011279 · ClinicalTrials.gov registry record · NA
Move Together Boston Feasibility Pilot (Sit Less, Move More App for Black Breast Cancer Survivors & At-Risk Relatives)
A NA study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT05011279 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 10 participants.
The verdict
NCT05011279, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to develop and test a mobile app for Black/African American breast cancer survivors and their relatives, called Move Together, that promotes sitting less and moving more for better health.
Interventions
- OTHER Move Together app/Garmin Activity Tracker
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-09-10 |
| Est. Completion | 2022-01-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05011279
The ClinicalTrials.gov registry entry for NCT05011279 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Move Together app/Garmin Activity Tracker is the first listed.
NCT05011279 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05011279 about?
NCT05011279 is a clinical study titled "Move Together Boston Feasibility Pilot (Sit Less, Move More App for Black Breast Cancer Survivors & At-Risk Relatives)". The purpose of this study is to develop and test a mobile app for Black/African American breast cancer survivors and their relatives, called Move Together, that promotes sitting less and moving more for better health.
What is the current status of trial NCT05011279?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2021-09-10. Estimated completion is 2022-01-21.
What interventions are being tested in trial NCT05011279?
The interventions under investigation include: Move Together app/Garmin Activity Tracker (OTHER).
Who is sponsoring clinical trial NCT05011279?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.